Share

Tobacco Control

ACS CAN supports a comprehensive approach to reducing tobacco use and exposure to secondhand smoke, including increasing taxes on all tobacco products, implementing comprehensive smoke-free laws, fully funding and sustaining evidence-based, statewide tobacco control programs, ensuring access to clinical cessation services and working with the Food and Drug Administration to regulate tobacco products and their marketing.

Tobacco Control Resources:

The Family Smoking Prevention and Tobacco Control Act (TCA) requires manufacturers of all new tobacco products to submit an application to the Food and Drug Administration’s Center for Tobacco Products (CTP) for premarket review to prove that the sale of their product is “appropriate for the protection of public health” prior to going on to the market. This is one of the most important provisions of the TCA, and was intended to prevent new, harmful tobacco products from ever being sold. Unfortunately, the premarket review of all new tobacco products has never taken full effect due to lack of enforcement by the agency, the tobacco industry continuing to sell new products without CTP authorization and implementation disruptions.

The Family Smoking Prevention and Tobacco Control Act (TCA) prohibits tobacco manufacturers from using misleading descriptors about their products and requires a substantive scientific review by the Food and Drug Administration's Center for Tobacco Products prior to using any "modified risk" claim. This is one of the most important provisions of the TCA as it directly addresses the tobacco industry's deceptive marketing practices about the harm of its products.

Tobacco use remains the leading cause of preventable death in the United States. No tobacco use is safe or without risk. Commerical tobacco product use, in any form, exposes the body to a myriad of dangerous chemicals and potential health risks.

Quitting tobacco can be challenging. However, a range of FDA-approved services are available to support individuals throughout this process.

The American Cancer Society Cancer Action Network (ACS CAN) supports a comprehensive approach to tobacco control that includes significantly increasing excise taxes on all tobacco products to generate revenue, protect kids, and save lives. Significant tobacco tax increases are one of the most effective ways to prevent kids from starting to use tobacco and help adults quit.

 

Llamado a la acción: La Red de Acción contra el Cáncer de la Sociedad Americana contra el Cáncer (ACS CAN) insta al Congreso a respaldar un financiamiento sostenido de $310 millones USD

In a letter to Interview magazine Editor and Chief Mel Ottenberg, the American Cancer Society Cancer Action Network (ACS CAN), alongside the American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, Truth Initiative, and Vital Strategies, expressed strong dis

In a letter to Vanity Fair Global Editorial Director Mark Guiducci, the American Cancer Society Cancer Action Network (ACS CAN), alongside the American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, Truth Initiative, and Vital Strategies, expressed strong disappoint

Regulation and Products Resources:

The Family Smoking Prevention and Tobacco Control Act (TCA) requires manufacturers of all new tobacco products to submit an application to the Food and Drug Administration’s Center for Tobacco Products (CTP) for premarket review to prove that the sale of their product is “appropriate for the protection of public health” prior to going on to the market. This is one of the most important provisions of the TCA, and was intended to prevent new, harmful tobacco products from ever being sold. Unfortunately, the premarket review of all new tobacco products has never taken full effect due to lack of enforcement by the agency, the tobacco industry continuing to sell new products without CTP authorization and implementation disruptions.

The Family Smoking Prevention and Tobacco Control Act (TCA) prohibits tobacco manufacturers from using misleading descriptors about their products and requires a substantive scientific review by the Food and Drug Administration's Center for Tobacco Products prior to using any "modified risk" claim. This is one of the most important provisions of the TCA as it directly addresses the tobacco industry's deceptive marketing practices about the harm of its products.

In March 2026, FDA released the “Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications – Considerations Related to Youth Risk; Draft Guidance for Industry." Draft Guidance provides FDA's current thinking about the topic of the guidance. The undersigned public health, medical, civil righs and community organizations conclude that the Draft Guidance fails to recognize the well-established history of signficant variations in youth flavor preferences over time, often caused by regulatory decisions, and this fundamental flaw threatens to open the regulatory door to a wide array of FDA-authorized products that would appeal and be accessible to youth, without signficant countervailing health benefits to adults who smoke.

American Academy of Pediatrics, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, and Campaign for Tobacco-Free Kids
oppose orders authorizing this claim because Swedish Match has failed to meet the statutory standard for the following reasons:
1. FDA’s past authorizations of a similar claim for General Snus should not determine whether the pending applications for ZYN nicotine pouches are granted because the
Tobacco Control Act requires product-specific analyses.
2. Significant differences between ZYN and General Snus – in use rates, relevant toxicology, flavors, and marketing – clearly warrant different consideration.
3. The applicant’s reliance on the “Swedish experience” is misleading and of limited relevance.
4. The applicant did not submit sufficient data on consumer perception or behavior change related to the proposed modified risk claim and this specific product.

Big tobacco has a history of prioritizing corporate profits over people and communities burdened by tobacco-related illness and death. For decades, the tobacco industry has lied to specific communities and the public at large saying their products are not addictive, harmful or deadly. Tobacco manufacturers continue to create and flood the market with newly designed products they market as being less harmful and alternatives to quitting – a tactic that is not new.

Smoke Free Resources:

The American Cancer Society Cancer Action Network (ACS CAN) calls on Congress to support a sustained level of funding of $310 million for tobacco control and reject the elimination of the Centers for Disease Control and Prevention’s Office on Smoking and Health (OSH).

Prevention and Cessation Resources:

Tobacco use remains the leading cause of preventable death in the United States. No tobacco use is safe or without risk. Commerical tobacco product use, in any form, exposes the body to a myriad of dangerous chemicals and potential health risks.

Quitting tobacco can be challenging. However, a range of FDA-approved services are available to support individuals throughout this process.

On April 15, 2026, the American Cancer Society Cancer Action Network, American Academy of Pediatrics, American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, and the Truth Initiative sent a letter to Dr. Jay Bhattacharya, in support of efforts to fully restore staff at the Centers for Disease Control and Prevention (CDC). The letter uplifts that reinstating capacity at the Office of Smoking and Health (OSH) at CDC is essential to ensuring congressionally appropriated funds are used effectively and that states, Tribal organizations, and territories receive uninterrupted funding, as well as technical assistance, and data-driven guidance. The letter underscores that without a fully staffed OSH, evidence-based programs that prevent youth initiation, help people quit, and reduce tobacco-related disease and costs nationwide are at serious risk. 

The American Cancer Society Cancer Action Network (ACS CAN) calls on Congress to support a sustained level of funding of $310 million for tobacco control and reject the elimination of the Centers for Disease Control and Prevention’s Office on Smoking and Health (OSH).

Big tobacco has a history of prioritizing corporate profits over people and communities burdened by tobacco-related illness and death. For decades, the tobacco industry has lied to specific communities and the public at large saying their products are not addictive, harmful or deadly. Tobacco manufacturers continue to create and flood the market with newly designed products they market as being less harmful and alternatives to quitting – a tactic that is not new.

Tobacco Taxes Resources:

The American Cancer Society Cancer Action Network (ACS CAN) supports a comprehensive approach to tobacco control that includes significantly increasing excise taxes on all tobacco products to generate revenue, protect kids, and save lives. Significant tobacco tax increases are one of the most effective ways to prevent kids from starting to use tobacco and help adults quit.

 

The economic model developed jointly by the Campaign for Tobacco-Free Kids (TFK), the American Cancer Society Cancer Action Network (ACS CAN), and Economics for Health (housed at the Johns Hopkins Bloomberg School of Public Health) projects the increase in state revenues, public health benefits, and health care cost savings resulting from increases in state cigarette tax rates.  The projections are updated annually.  Calculations are based on economic modeling by Frank Chaloupka, Ph.D., and John Tauras, Ph.D., at the Institute for Health Research and Policy at the University of Illinois at Chicago, Jidong Huang, Ph.D., at Georgia State University, and Michael Pesko, Ph.D., at the University of Missouri.

The American Cancer Society Cancer Action Network (ACS CAN) calls on Congress to support a sustained level of funding of $310 million for tobacco control and reject the elimination of the Centers for Disease Control and Prevention’s Office on Smoking and Health (OSH).